Advanced Search

    column
    Re-evaluation of Adjuvant Therapy for Early Stage Non-Small Cell Lung Cancer
    WU Yi-long
    2006, 6(4): 193-195. DOI: 10.3969/j.issn.1671-5144.2006.04.001
    Abstract PDF
    Long-Term Results of Phase Ⅱ Trial of Postoperative Adjuvant Paclitaxel/Carboplatin and Thoracic Radiotherapy in Resected Stage Ⅱ and Ⅲ A Non-Small Cell Lung Cancer
    JIANG Guo-liang, WANG Zhen
    2006, 6(4): 196-200. DOI: 10.3969/j.issn.1671-5144.2006.04.002
    Abstract PDF
    Compliance with Post-Operative Adjuvant Chemotherapy in Non-Small Cell Lung Cancer in Clinical Trial JBR.10
    WANG Jie, ZHOU Qing
    2006, 6(4): 201-203. DOI: 10.3969/j.issn.1671-5144.2006.04.003
    Abstract PDF
    A Systematic Review of Adjuvant Chemotherapy for Completely Resected Non-Small Cell Lung Cancer
    YU Shi-ying, XU Chong-rui
    2006, 6(4): 204-207. DOI: 10.3969/j.issn.1671-5144.2006.04.004
    Abstract PDF
    The Possibility of Identifying Cisplatin-Based Adjuvant Chemotherapy Responders by Novel Biomarker
    ZHOU Cai-cun, DONG Song
    2006, 6(4): 208-210. DOI: 10.3969/j.issn.1671-5144.2006.04.005
    Abstract PDF
    Assessment of the Efficacy and Safety of Bevacizumab Plus Carboplatin and Paclitaxel in Patients with Non-Small Cell Lung Cancer
    LU Shun, ZHU Jian-quan
    2006, 6(4): 211-212. DOI: 10.3969/j.issn.1671-5144.2006.04.006
    Abstract PDF
    Phase Ⅰ/Ⅱ Trial Evaluating Bevacizumab in Combination with Erlotinib for Patients with Recurrent Non-Small Cell Lung Cancer
    ZHANG Li, ZHANG Guo-chun
    2006, 6(4): 213-215. DOI: 10.3969/j.issn.1671-5144.2006.04.007
    Abstract PDF
    Comparison between RFA with PEI in the Treatment of Small HCC:A Systematic Review
    Li Quan-bo, CHEN Ru-fu, LI Zhi-hua, GUO Shuang-shuang, ZHOU Jia-jia, LIN Qing, ZHONG Feng, CHEN Ji-sheng, WANG Jie
    2006, 6(4): 216-222. DOI: 10.3969/j.issn.1671-5144.2006.04.008
    Abstract PDF
    A Comparison of Intravesical Bacillus Calmette-Guerin Versus Mitomycin C for Superficial Bladder Cancer of Chinese Postoperatively on Recurrence and Toxicity(Meta-Analysis)
    LAN Wei-hua, JIN Feng-shuo, WANG Luo-fu, SUN Zhong-yi, ZHANG Jun, ZHANG Yao
    2006, 6(4): 223-226. DOI: 10.3969/j.issn.1671-5144.2006.04.009
    Abstract PDF
    Chinese Consensus on Bronchioloalveolar Cell Carcinoma
    WU Yi-long, JIANG Guo-liang, LU Shun, ZHOU Qing-hua, ZHANG Li
    2006, 6(4): 227-230. DOI: 10.3969/j.issn.1671-5144.2006.04.010
    Abstract PDF
    An Interview in Chinese Lung Cancer Summit Forum 2006
    YU Lin, ZHANG Hua
    2006, 6(4): 231-235. DOI: 10.3969/j.issn.1671-5144.2006.04.011
    Abstract PDF
    Re-discussion in "China Lung Cancer Practice Guideline"
    HU Chen-ping
    2006, 6(4): 236-237. DOI: 10.3969/j.issn.1671-5144.2006.04.012
    Abstract PDF
    NCCN Palliative Care Practice Guidelines
    QIU Hong, YU Shi-ying
    2006, 6(4): 238-253. DOI: 10.3969/j.issn.1671-5144.2006.04.013
    Abstract PDF
    Could Lung Cancer Patients without Accurate Pathological Diagnosis Get the Anticancer Treatment? (3)
    MA Sheng-lin, ZHANG Xi-zeng, LI Kai, ZHOU Cai-cun, CHEN Gang
    2006, 6(4): 254-256. DOI: 10.3969/j.issn.1671-5144.2006.04.014
    Abstract PDF